CN1164855A - 含有连接碳环的取代苯并咪唑碱的抗病毒核苷类似物 - Google Patents
含有连接碳环的取代苯并咪唑碱的抗病毒核苷类似物 Download PDFInfo
- Publication number
- CN1164855A CN1164855A CN95196148A CN95196148A CN1164855A CN 1164855 A CN1164855 A CN 1164855A CN 95196148 A CN95196148 A CN 95196148A CN 95196148 A CN95196148 A CN 95196148A CN 1164855 A CN1164855 A CN 1164855A
- Authority
- CN
- China
- Prior art keywords
- chloro
- benzoglyoxaline
- methylol
- compound
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/304,006 US5534535A (en) | 1992-03-09 | 1994-09-09 | Therapeutic nucleosides |
US08/304,006 | 1994-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1164855A true CN1164855A (zh) | 1997-11-12 |
Family
ID=23174626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95196148A Pending CN1164855A (zh) | 1994-09-09 | 1995-09-11 | 含有连接碳环的取代苯并咪唑碱的抗病毒核苷类似物 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0779885A1 (fr) |
JP (1) | JPH10505092A (fr) |
CN (1) | CN1164855A (fr) |
AP (1) | AP741A (fr) |
AU (1) | AU3692895A (fr) |
BR (1) | BR9508826A (fr) |
CA (1) | CA2199502A1 (fr) |
CZ (1) | CZ71297A3 (fr) |
FI (1) | FI970959A (fr) |
HU (1) | HUT77440A (fr) |
IS (1) | IS4436A (fr) |
NO (1) | NO971070L (fr) |
NZ (1) | NZ294095A (fr) |
OA (1) | OA10601A (fr) |
PL (1) | PL319440A1 (fr) |
SK (1) | SK29197A3 (fr) |
WO (1) | WO1996007646A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1834090B (zh) * | 2005-03-18 | 2011-06-29 | 中国科学院上海药物研究所 | 苯并咪唑类化合物、其制备方法以及用途 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5912356A (en) * | 1995-09-11 | 1999-06-15 | Glaxo Wellcome Inc. | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
JP2001512453A (ja) | 1997-02-13 | 2001-08-21 | グラックス グループ リミテッド | ベンゾイミダゾール誘導体 |
EP1000080A1 (fr) | 1997-07-30 | 2000-05-17 | The Regents of The University of Michigan | Benzimidazoles de lyxofuranosyle en tant qu'agents antiviraux |
TR200103147T1 (tr) | 1999-12-27 | 2002-06-21 | Japan Tobacco Inc. | Kaynaşık halkalı bileşikler ve bunların ilaç olarak kullanımı. |
US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
ES2757928T3 (es) | 2007-08-02 | 2020-04-30 | Millennium Pharm Inc | Proceso para la síntesis de inhibidores de enzimas activadoras E1 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
-
1995
- 1995-09-11 CA CA002199502A patent/CA2199502A1/fr not_active Abandoned
- 1995-09-11 CN CN95196148A patent/CN1164855A/zh active Pending
- 1995-09-11 WO PCT/US1995/011366 patent/WO1996007646A1/fr not_active Application Discontinuation
- 1995-09-11 CZ CZ97712A patent/CZ71297A3/cs unknown
- 1995-09-11 AP APAP/P/1997/000940A patent/AP741A/en active
- 1995-09-11 EP EP95934402A patent/EP0779885A1/fr not_active Withdrawn
- 1995-09-11 BR BR9508826A patent/BR9508826A/pt not_active Application Discontinuation
- 1995-09-11 NZ NZ294095A patent/NZ294095A/en unknown
- 1995-09-11 HU HU9702310A patent/HUT77440A/hu unknown
- 1995-09-11 SK SK291-97A patent/SK29197A3/sk unknown
- 1995-09-11 PL PL95319440A patent/PL319440A1/xx unknown
- 1995-09-11 JP JP8509679A patent/JPH10505092A/ja not_active Ceased
- 1995-09-11 AU AU36928/95A patent/AU3692895A/en not_active Abandoned
-
1997
- 1997-03-06 FI FI970959A patent/FI970959A/fi unknown
- 1997-03-07 OA OA60973A patent/OA10601A/en unknown
- 1997-03-07 IS IS4436A patent/IS4436A/is unknown
- 1997-03-07 NO NO971070A patent/NO971070L/no unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1834090B (zh) * | 2005-03-18 | 2011-06-29 | 中国科学院上海药物研究所 | 苯并咪唑类化合物、其制备方法以及用途 |
Also Published As
Publication number | Publication date |
---|---|
AP9700940A0 (en) | 1997-04-30 |
NO971070L (no) | 1997-05-07 |
CZ71297A3 (en) | 1997-08-13 |
FI970959A0 (fi) | 1997-03-06 |
FI970959A (fi) | 1997-05-06 |
AU3692895A (en) | 1996-03-27 |
BR9508826A (pt) | 1997-09-30 |
IS4436A (is) | 1997-03-07 |
MX9701789A (es) | 1997-10-31 |
NZ294095A (en) | 1998-08-26 |
WO1996007646A1 (fr) | 1996-03-14 |
PL319440A1 (en) | 1997-08-04 |
SK29197A3 (en) | 1997-10-08 |
OA10601A (en) | 2002-09-03 |
JPH10505092A (ja) | 1998-05-19 |
EP0779885A1 (fr) | 1997-06-25 |
AP741A (en) | 1999-04-26 |
NO971070D0 (no) | 1997-03-07 |
CA2199502A1 (fr) | 1996-03-14 |
HUT77440A (hu) | 1998-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4399478B2 (ja) | 1−(2−(ヒドロキシメチル)−1,3−オキサチオラン−5−イル)−5−フルオロシトシンのb型肝炎治療への使用 | |
CN1045089C (zh) | 2-(2-氨基-1,6-二氢-6-氧代-嘌呤-9-基)甲氧基-1,3-丙二醇衍生物 | |
KR960002849B1 (ko) | 아사이클로비르의 발린 에스테르 및 이를 함유하는 약학 조성물 | |
JP3172533B2 (ja) | 治療用ヌクレオシド | |
CN1052010C (zh) | 苯并咪唑衍生物及其制备方法和用途以及含该衍生物的药物制剂 | |
AU2012296622B2 (en) | Tenofovir alafenamide hemifumarate | |
CN1042331C (zh) | 4,6-二氯-3-取代的-2-羧基吲哚衍生物 | |
JP3450854B2 (ja) | 抗ウイルス性ヌクレオシド類縁体 | |
CN1164855A (zh) | 含有连接碳环的取代苯并咪唑碱的抗病毒核苷类似物 | |
CN1212683A (zh) | 具有抗病毒活性的2-氨基-5,6-二氯苯并咪唑衍生物 | |
CN1269801A (zh) | 作为抗病毒剂的嘌呤非环核苷 | |
CN1214049A (zh) | 治疗性化合物 | |
CN1906196A (zh) | 具有hiv和hcv抗病毒活性的4'-取代的卡波韦-和阿巴卡韦-衍生物以及相关化合物 | |
CN1036398C (zh) | 治疗用核苷 | |
JPH06506929A (ja) | B型肝炎ウイルス感染の治療のための、1,3−オキサチオラン誘導体の使用 | |
US6630477B1 (en) | Therapeutic nucleoside compound | |
AU2014271320B2 (en) | Tenofovir alafenamide hemifumarate | |
CN1840538A (zh) | 1-(2′-脱氧-2′-氟-3′-O-氨基酸酯-β-L-呋喃阿拉伯糖基)-5-甲基尿嘧啶及其应用 | |
MXPA97001789A (en) | Antiviral nucleosid analogues containing a substitute benzymidazole base united to a carbocicl ring | |
NZ620421B2 (en) | Tenofovir alafenamide hemifumarate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |